Pharmaceutical preparations acting on skin sales in the US experienced significant changes from 2013 to 2023, growing from $2.6238 billion to $4.9294 billion. Key trends included a notable spike in 2015 and a decline in 2020, likely influenced by the pandemic. By 2023, the market showed resilience with a 1.86% year-over-year increase. Over the past five years, the CAGR stands at approximately 2.01%, indicating a moderate growth trend.

Future trends to watch for:

Continued market stability with a forecasted 1.4% CAGR from 2024 to 2028.
Increased demand for innovative skincare treatments and products.
Impact of regulatory changes on market dynamics.
Advances in technology and personalized medicine influencing product development.